Introduction
Histamine plays a pivotal role in a number of processes, including infl ammation, allergic reaction, gastric acid secretion and neurotransmission. Expression of histidine decarboxylase (HDC), the key enzyme in the synthesis of histamine, has been shown to be increased in colorectal carcinoma [1] and other types of human tumors, suggesting that histamine may be directly involved in tumor development and progression. Histamine has been shown to stimulate the in vitro and in vivo growth of gastrointestinal cancer cells while treatment with cimetidine, an H 2 receptor antagonist, can reverse this effect [2] . Histamine also seems to be involved in the inhibition of local immune response against cancer. At increased pathophysiological concentrations histamine can exert potent immunosuppressive effects by activating T cell suppressor function and inhibiting lymphocyte proliferation [3, 4] . In the present study, we addressed the hypothesis that activation of the COX-2 pathway mediates the possible link between histamine and colorectal cancer.
Materials and methods

Patients and tissue collection
Tissue samples were obtained from 33 patients (15 males, 18 females, median age 65 years) who had consecutively undergone surgical resections for primary sporadic colorectal adenocarcinomas at the Department of General Surgery, University of Florence, Italy. The patients had not undergone any chemotherapy or other chronic pharmacological treatment. All patients were informed about the aims of the study and gave written consent for the investigation in accordance with the ethical guidelines of our University. Tumors were classifi ed into four stages according to the AJCC staging system. Tissues from the edge of the tumor and normal mucosa 10 cm away from the tumor were excised from each patient. The samples were washed in PBS and frozen at -80°C until use; other samples were fi xed in 4 % formaldehyde and embedded in paraffi n for immunostaining as previously described [5] .
Biochemical determinations
Histamine content was determined after butanol/heptan tissue extraction, using a previously reported fl uorimetric method [6] . PGE 2 production was measured using 100 µl of the supernatant of tissue homogenate using a competitive enzyme immunoassay kit (Cayman Chemical Co, Ann Arbor, MI, USA) according to a previously described method [7] . Cyclic AMP (cAMP) levels were measured in the aqueous phase of tissue homogenates extracted from 10 % trichloroacetic acid with 0.5 mol/ L tri-N-octylamine dissolved in 1,1,2-trichlorofl uoroethane. cAMP was measured with commercially available radioimmunoassay.
Statistical analysis
Histamine, PGE 2 and cAMP content were expressed as mean values +/ -standard error of mean (SEM). The extent of tumor infi ltration by lymphocytes was classifi ed as absent/little, moderate and diffuse. The relationships among histamine content, PGE 2 production and lymphocyte infi ltrate were evaluated using the Spearmann correlation coeffi cient (r s ). P values less than .05 were considered statistically signifi cant.
Results and discussion
Histamine content was signifi cantly higher in the tumor specimens than in the corresponding normal mucosa and was also higher in tumors with lymph node and/or distant metastases (stage III-IV) than in those without any metastases (stage I-II) as we have previously reported [8] . Our present results evidentiated a signifi cant correlation between histamine content and PGE 2 production (Fig.1A) . We also found a signifi cant correlation between histamine content and cAMP production (r s = 0.3.5, p = 0.02) in tumor samples. Our results showed also that the extent of intratumor lymphocyte infi ltrate increased as histamine content decreased (Fig. 1B) .
Our study shows that high levels of histamine content are correlated with the presence of lymph node and/or distal metastases in colorectal cancer. Moreover we found a signifi -cant correlation between these parameters and PGE 2 levels as well as between histamine and tumor production of cAMP that is one of the most important intracellular mediators of PGE 2 .
Much experimental evidence demonstrates the close involvement of COX-2 activity and thus, PGE 2 production, in tumor proliferation and progression [5] . Histamine has been reported to have an immunosuppressive effect through negative regulation of helper T-cell functions [3, 4] . The presence of tumor infi ltrating lymphocytes within colorectal tumor tissues is considered to be a marker of good prognosis; histamine content is inversely correlated with the extent of intratumor lymphocyte infi ltrate.
Although we did not address the mechanisms by which histamine may modulate immune response, our fi ndings support the hypothesis that histamine may negatively regulate lymphocyte proliferation and chemotaxis in the tumor microenvironment.
In conclusion, our fi ndings supported the hypothesis that the high histamine content of tumor may represent one of the underlying causes of local decreased immune surveillance against colon cancer. 
